Computational exploration of global venoms for antimicrobial discovery with Venomics artificial intelligence. [PDF]
Guan C +3 more
europepmc +1 more source
Redox-Active Conopeptide Li520 Has Evolved to Catalyze Oxidative Folding of Conotoxins. [PDF]
Dhannura S +8 more
europepmc +1 more source
Spider venom peptides with unique fold selectively block Shaker-type potassium channels. [PDF]
Kuzmenkov AI +11 more
europepmc +1 more source
Fish-hunting cone snail disrupts prey's glucose homeostasis with weaponized mimetics of somatostatin and insulin. [PDF]
Yeung HY +16 more
europepmc +1 more source
Peptides from Animal Venoms: A Promising Frontier in Diabetes Therapy via Multi-Target Mechanisms. [PDF]
de Almeida JOCS +4 more
europepmc +1 more source
Exploring the Pain-Relieving Potential: Unveiling Antinociceptive Properties in Animal Venoms and Toxins. [PDF]
Angstmam DG +6 more
europepmc +1 more source
Related searches:
Therapeutic Potential of Cone Snail Venom Peptides (Conopeptides)
Current Topics in Medicinal Chemistry, 2012Cone snails have evolved many 1000s of small, structurally stable venom peptides (conopeptides) for prey capture and defense. Whilst < 0.1% have been pharmacologically characterised, those with known function typically target membrane proteins of therapeutic importance, including ion channels, transporters and GPCRs. Several conopeptides reduce pain in
Vetter, Irina, Lewis, Richard J.
openaire +3 more sources
Ichthyotoxicity caused by marine cone snail venoms?
Toxicon, 2005Ten venoms from marine cone snails were tested for ichthyotoxic effects on zebra fish (Brachydanio rerio) when added to the water. Only two venoms, from Conus capitaneus and Conus episcopatus, produced lethal effects at high concentrations (50-300 microg/ml) within 20-90 min. No sedative or hypnotic symptoms were observed.
Dietrich, Mebs, Silke, Kauferstein
openaire +2 more sources
Cone Snail Venomics: From Novel Biology to Novel Therapeutics
Future Medicinal Chemistry, 2014Peptide neurotoxins from cone snails called conotoxins are renowned for their therapeutic potential to treat pain and several neurodegenerative diseases. Inefficient assay-guided discovery methods have been replaced by high-throughput bioassays integrated with advanced MS and next-generation sequencing, ushering in the era of 'venomics'. In this review,
Prashanth, Jutty Rajan +5 more
openaire +3 more sources

